REFERÊNCIAS
1 Liddy N and Stuart J. Sympathetic ophthalmia in Canada. Can Ophthalmol 1972;7:157-9.
2 Albert DM and Diaz-Rohena R. A historical review of sympathet c ophthalmia and its epidemiology. Surv Ophthalmol 1989;34:1-14.
3 Jennings T and Tessler HH. Twenty cases of sympathetic oph:halmia. Br J Ophthalmol 1989;73: 140-5.
4 Chan CC, Roberge FG, Whitcup SM, Nussenblatt RB. 32 Cases of Sympathetic ophthalmia. Arch Ophthalmol 1995; 113:597-600.
5 Jakobiec FA, Marboe CC, Knowles II DM, lwamoto T, Harrison W, Chang S, Coleman J. Human sympathetic ophthalmia: an analysis of the nflammatory infiltrate by hybridoma-monoclonal antibodies, imunochemistry, and correlative eletron microscopy. Ophthalmology 1983;90:76-95.
6 Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. Antiretinal autoantibodies in Vogt-Koyanagi-Harada syndrome, Behçet's disease, and sympathetic ophthalmia. Ophthalmology 1985;92: 1025-8.
7 Power WJ & Foster CS. Update on sympathetic ophthalmia. Inl Ophthalmol Clin 1995;35:127-37.
8 Pereira MB & Pereira CM. Oftamia simpática após traumatismo ocular contuso. Rev Bras Oftalmol 1996;55:35-40.
9 Lubin JR, Albert DM, Weinstein M. Sixty fiveyears of sympathetc ophthalmia: a clinicopathological review of 105 cases (1913-1978). Ophthalmology 1980;87:109-21.
10 Wong VG, Anderson R, O'Brien PJ. Sympathetic ophthalmia and lymphocyte transforrnation. Am J Ophthalmol 1971;72:960-5.
11 Gomes JAP, Rizzo LV, Nishi M, Donoso LA, Dua HS. Influência do epitélio corneal limbar sobre a expressão do antígeno dos linfócitos da mncosa humana (Hml-1). Arq Bras Oftalmol 1997;60:588-97.
12 Kim MK & Belfort Jr R. Uveíte facogênica. In: Oréfice F & Belfort Jr R, eds. Uveítes. São Paulo: Livraria Roca Ltda., 1987;310.
13 Reynard M, Schulman IA, Azen SP, Minckler D. Histocompatibility antigens in sympathetic ophthalmia. Am J Ophthalmol 1983;95:216-21.
14 Dick AD, Azim M, Forrester JV. Immunosuppressive therapr for chronic uveitis: optimising therapy with steroids and cyclosporin A. Br J Ophthalmol 1997;81:1107-12.